Form D · Other
CYTEGEN CORP
Shorewood, WI · CIK 0001735962
Offering snapshot reported Jan 13, 2022 · SEC filing
- Reported sold
- $1.1M Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Dec 3, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 13, 2022 | Initial | $1,100,002 | No comparison | 3 | SEC filing |
| Apr 13, 2018 | Amendment | $1,000,000 | $0vs Apr 10, 2018 | 4 | SEC filing |
| Apr 10, 2018 | Initial | $1,000,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-429165
Source: Form D, filed Jan 13, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Harte | Director |
| George Ugras Nuray | Director, Executive |
| Nuray George Ugras | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
4230 N. Oakland Avenue #154
Shorewood, WI, 53211
Shorewood, WI, 53211